Moderna, Inc.
Moderna, Inc.
CAMBRIDGE, MA
Loading...
Price History
Market Data
| Market Cap | 46.31M |
| P/E Ratio | - |
| P/B Ratio | 0.01 |
| EPS | - |
| Dividend Yield | - |
| D/E Ratio | 0.43 |
| Current Ratio | 3.29 |
| Currency | USD |
Key Financial Metrics
1.94B
Revenue
-2.82B
Net Income
-
EPS (Diluted)
-5.29B
Free Cash Flow
Profitability
Gross Margin
55.3%
Operating Margin
-158.1%
Net Profit Margin
-145.2%
EBITDA
-3.07B
Returns & Efficiency
Return on Assets (ROA)
-22.9%
Return on Equity (ROE)
-32.6%
Dividend Yield
-
EPS
-
Financial Health
Total Assets
12.34B
Total Debt
590.00M
Debt to Equity
0.43x
Current Ratio
3.29
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Chemicals & Allied Products |
| HQ | CAMBRIDGE, MA |
| Fiscal Year | 2025 |
Peers
AMGEN INC
AMGN
177.13B
P/E: --
GILEAD SCIENCES INC
GILD
166.13B
P/E: --
166.13B
P/E: --
BIOGEN IDEC INC.
BIIB
27.90B
P/E: --
BIOGEN INC.
BIIB
27.90B
P/E: --
19.11B
P/E: --
13.53B
P/E: 32.5
EXELIXIS, INC.
EXEL
11.29B
P/E: 18.6
Quick Links
Financial Statistics
Valuation
Market Cap$46.31M
P/E Ratio (TTM)-
Price to Book0.01
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin55.3%
Operating Margin-158.1%
Net Margin-145.2%
ROE-32.6%
ROA-22.9%
Leverage & Liquidity
Debt to Equity0.43
Current Ratio3.29
Total Debt$590.00M
Total Assets$12.34B
Stockholders' Equity$8.65B
Income Statement (FY 2025)
Revenue$1.94B
Gross Profit$1.08B
Operating Income$-3.07B
Net Income$-2.82B
EPS (Diluted)-
Cash Flow (FY 2025)
Free Cash Flow$-5.29B
Cash & Equivalents$2.60B
Revenue Growth-39.9%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 325 BINNEY STREET CAMBRIDGE, MA 02142 |
| Phone | N/A |
| Incorporated | DE, US |
| EIN | 813467528 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 1.00M |
| Stockholders' Equity | $8.65B |
| Cash & Equivalents | $2.60B |
Recent Filings
View All
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-05-04
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-06
Local
DEFA14A
Additional Proxy Materials
Additional definitive proxy soliciting materials
Filed: 2026-03-16
Local
DEF 14A
Definitive Proxy Statement
Official proxy statement for shareholder voting
Filed: 2026-03-16
Local
ARS
Annual Report to Shareholders
Annual report furnished to shareholders
Filed: 2026-03-16
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-05
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | Moderna, Inc. |
| Ticker | MRNA |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Chemicals & Allied Products |
| Headquarters | CAMBRIDGE, MA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 46.31M |
| Revenue | 1.94B |
| Net Income | -2.82B |
| P/E Ratio | - |
| EPS | - |
| Net Margin | -145.2% |
| ROE | -32.6% |
| Dividend Yield | - |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...